Connecting clients, partners and patients to develop new treatments for diabetes and related metabolic diseases.
Clinical Development and Regulatory Strategy + State-of-the-Art Clinical Facility + Full Scope CRO Services + Global Scientific Network
ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit Read More »
ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon Read More »
View Our Presentation
Single Dose Euglycemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between MK-1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Type 1 Diabetes and Healthy Subjects Read More »
FDA approves Ozempic to improve glycemic control in adults with T2D Read More »
Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development Read More »